Chimeric antigen receptor T (CAR-T) cell therapy has emerged as a transformative approach in modern medicine, demonstrating remarkable efficacy in targeting pathogenic B-cell lineages with unprecedented specificity. Originally developed for B cell malignancies, this innovative immunotherapy has recently shown extraordinary potential in treating various autoimmune diseases by depleting autoreactive B cells and effectively resetting the immune system. The review by Qi Li and colleagues provides a comprehensive examination of the progression, clinical applications, challenges, and future directions of B cell-targeted CAR-T therapy across multiple autoimmune conditions.

Extensive bone defects pose substantial clinical challenges, frequently resulting in severe functional impairment and diminished quality of life for patients. Conventional therapeutic approaches, including autografts and allografts, remain widely utilized despite significant drawbacks such as donor site morbidity, limited availability, and potential immunogenic responses. Consequently, tissue engineering has emerged as an increasingly attractive alternative strategy. Bioceramic bone repair materials offer dual functionality by providing essential mechanical support while delivering bioactive properties that facilitate defect healing. A critical aspect of their therapeutic efficacy lies in their capacity to modulate the immune microenvironment, thereby promoting cellular behaviors and signaling pathways that favor bone regeneration. These immunoregulatory effects prove instrumental throughout the entire bone repair process and largely determine the ultimate success of regenerative outcomes. For example, hydroxyapatite demonstrates the ability to induce macrophage polarization toward the M2 phenotype, generating anti-inflammatory effects that enhance bone tissue repair. A comprehensive review published in Frontiers of Medicine systematically examines recent progress in bioceramic research for bone tissue engineering, encompassing material classification, immunomodulatory mechanisms, contemporary fabrication methodologies, and clinical translation status, with the objective of informing future investigations and improved therapeutic strategies.

Discovery reveals how drug-resistant tumours can shift into a state that responds better to chemotherapy.

Cardiovascular disease remains the leading cause of mortality worldwide, necessitating deeper insights into its molecular underpinnings beyond genetic predisposition. Epigenetic modifications, particularly methylation changes affecting DNA, proteins, and RNA, have emerged as critical regulators of gene expression implicated in cardiac pathophysiology. These heritable yet reversible chemical alterations govern chromatin architecture, transcriptional activity, and post-transcriptional processing without changing underlying nucleotide sequences. Within the spectrum of cardiovascular pathology—including ischemic heart disease, cardiac hypertrophy, heart failure, and atherosclerosis—dysregulated methylation patterns contribute substantially to disease initiation, progression, and phenotypic manifestation. Understanding the distinct and convergent roles of these three major methylation modalities offers promising avenues for developing novel diagnostic biomarkers and targeted therapeutic interventions that could transform precision medicine in cardiology.

Deep tissue injury (DTI) is a serious condition primarily triggered by prolonged mechanical loading rather than short-term excessive force. Cyclic force stimulation has been shown to enhance cellular protection; however, the biomechanical mechanisms underlying tissue and cellular responses to such stimulation remain poorly understood.

Circulating tumor cells (CTCs) are cancerous cells that break away from the primary tumor, enter the bloodstream, and travel to another part of the body. Research into CTCs, particularly their biological phenotypes and molecular mechanisms, has provided critical insights into metastasis and potential therapeutic targets.

Intravital mesoscale imaging plays a crucial role in bridging the gap between cellular and organ-level investigations by enabling high-resolution visualization across large fields of view. Continuous advancements in optical microscopy have significantly improved imaging performance, yet fundamental challenges remain.

Bird migration is awe-inspiring. Animals mostly made of feathers take to the sky and complete round-trip journeys up to 40,000 kilometers long. The extremists migrate nonstop. Some fast the entire way. Most migratory species, however, engage in what ornithologists refer to as “stopovers” to refuel, rest, and wait out storms. A new literature review published in the Journal of Raptor Research emphasizes the need for more investigation into the importance of these stopover sites, newly defined in the review as places where individuals “pause their migratory movements for at least twenty-four hours.” Raptors are top predators with far-reaching impacts on their surrounding habitat, and they respond quickly to environmental change, making them effective bioindicators. Bolstering our knowledge of which areas are most crucial to the success of these long-distance journeys is therefore necessary, and increasingly possible as tracking technology improves. 

Researchers from the Center of Excellence in Marine Biotechnology at Sultan Qaboos University (SQU), in collaboration with Macro Algae Industries, have launched a pilot seaweed farm near the Al Sawadi Islands in Barka to evaluate the commercial feasibility of cultivating native seaweed species in Omani waters.